Abstract
Background: We have previously demonstrated that the presence of depression/anxiety reduces the probability of achieving sustained Minimal Disease Activity (MDA) in patients with psoriatic arthritis (PsA). Objective: We now aimed to investigate whether the presence of depression/anxiety affects the likelihood of achieving components of MDA in patients with PsA. Design: Observational cohort study using longitudinal data from a prospective PsA cohort. Methods: We included PsA patients satisfying classification criteria, prospectively followed from 2008 to 2024. We defined the presence of depression/anxiety by one of three criteria 1 a score of ≤38 on the SF-36 Mental Component Summary score, 2a score of ≤56 on the SF-36 Mental Health domain, or 3 a rheumatologist’s report of a diagnosis or treatment for depression/anxiety. Generalized Estimating Equations were utilized to evaluate the association between depression/anxiety and being in a state of MDA, as well as each of the seven MDA components. Results: Among 1,130 PsA patients studied, 659 patients (58.3%) met at least one definition of depression/anxiety. The presence of depression/anxiety was associated with a 63% lower likelihood of achieving MDA. Patients with depression/anxiety were significantly less likely to 6 of the 7 MDA criteria, including tender joint count ≤1, swollen joint count ≤1, tender entheseal points ≤1, pain visual analogue scale (VAS) ≤15, global disease activity VAS ≤20, and HAQ score ≤0.5. No association was found between depression/anxiety and achieving PASI≤1. Conclusion: In PsA patients, the presence of depression/anxiety reduces the odds of achieving all criteria of MDA except PASI.
Funding Information
  • Krembil Foundation
  • Schroeder Arthritis Institute

This publication has 34 references indexed in Scilit: